Exhibit 11.1 INNOVIR LABORATORIES, INC. STATEMENT OF COMPUTATION OF PER SHARE DATA For the three months ended June 30, --------------------------------------------------------- 1996 1995 --------------------------------------------------------- Fully Fully Primary Diluted Primary Diluted ----------- ----------- ----------- ----------- Net loss ............................................................... ($3,373,120) ($3,373,120) ($1,344,232) ($1,344,232) Reduction of net loss assuming a portion of the proceeds from the exercise of options and warrants was used to repay the Company's term note payable and related accrued interest, and capital lease obligations and to invest in short-term government securities, in accordance withthe treasury stock method .............. 3,000 538,006 ----------- ----------- ----------- ----------- Net loss ............................................................ ($3,373,120) ($3,370,120) ($1,344,232) ($ 806,226) =========== =========== =========== =========== Weighted average number of common shares outstanding ................................................... 5,740,638 5,740,638 3,589,496 3,589,496 Weighted average shares issuable upon conversion of convertible equity securities .......................... 1,748,994 363,563 Shares issuable upon exercise of outstanding options and warrants ..................................... 1,635,360 6,708,289 Shares assumed to be purchased under the treasury stock method ................................................ (1,174,902) (728,205) ----------- ----------- ----------- ----------- Weighted average number of common shares used in computing per share data .............................. 5,740,638 7,950,090 3,589,496 9,933,143 =========== =========== =========== =========== Net loss per share ................................................... ($0.59) ($0.42) ($0.37) ($0.08) =========== =========== =========== ===========